| | | 61225 | | 14.10.2010 | | Teva Pharma AG | | | | | | | | | | | | | 70000. | | | | 07.16.10. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Temozolomid-Teva 5 mg | Hartkapseln | Capsules (Temozolomide 5 mg, Ammonii Hydroxidum 0 ) | L01AX03 | IPat | | 02 | Temozolomid-Teva 20 mg | Hartkapseln | Capsules (Temozolomide 20 mg, Ammonii Hydroxidum 0 ) | L01AX03 | IPat | | 03 | Temozolomid-Teva 100 mg | Hartkapseln | Capsules (Temozolomide 100 mg, Ammonii Hydroxidum 0 ) | L01AX03 | IPat | | 04 | Temozolomid-Teva 140 mg | Hartkapseln | Capsules (Temozolomide 140 mg, Ammonii Hydroxidum 0 ) | L01AX03 | IPat | | 05 | Temozolomid-Teva 180 mg | Hartkapseln | Capsules (Temozolomide 180 mg, Ammonii Hydroxidum 0 ) | L01AX03 | IPat | | 06 | Temozolomid-Teva 250 mg | Hartkapseln | Capsules (Temozolomide 250 mg) | L01AX03 | IPat |
|
|
